Eykona Technologies Ltd spins out of Oxford
New spin-out company aims for 3D imaging at home.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
New spin-out company aims for 3D imaging at home.
There has been increased interest in the impact of publicly funded research since the publication in July 2006 of a report on “Increasing the economic impact of the Research Councils”, known as the Warry Report. The Report was largely critical and the Research Councils have been forced to respond defensively.
EKB Technology Ltd, provider of a completely new and patent pending bioprocessing technology, has been successful in raising £325,000 from the Oxford Technology 4 Venture Capital Trust.
Third Phase Limited, a high-tech company spun out from Oxford University's Department of Engineering Science and now based on the Cambridge Science Park, is pleased to announce that it has merged with the Cmed Group Ltd, opening up tremendous development opportunities for both companies.
OxLoc today announced changes to its Board of Directors so as to support the Company’s rapid commercial progress of its novel, battery-powered asset tracking technology. As of 1 st August 2005, Daniel Burnett, currently a non-executive director will become Non Executive Chairman of OxLoc.
Oxford Immunotec, the T cell diagnostics company, announced today that it has closed a £7M series B private equity financing.
Devices Enable 24-hour Monitoring of Non-Powered Assets, Increased Asset Utilization and Efficiency, Visible Asset Management, Improved Security, and Minimized Theft/Damage/Loss for up to 3 years
A new spin-out from Oxford University, Spinox, is aiming to devise novel ways to copy spiders' ability to spin silks. The new silks may be used for sutures or woven material for surgical implants, protective clothing and in sports equipment.
Oxitec Ltd is pleased to announce that it is a member of a consortium that has been offered funding to develop new genetic strategies for control of dengue virus.
Oxitec Limited announces the completion of its second funding round of £1.3m, led by Oxford Capital Partners. The existing investors, East Hill Advisors, LLC from Boston and the University of Oxford (through the Isis College Fund), have made further investments in the company as part of this round. Oxford Capital Partners invested £550,000.